RSS Subscribe to our Nanotechnology Business News feed

BIND Therapeutics and Roche Collaborate on Discovery of Novel Nanomedicines

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, today announced that it has entered into a research agreement with Roche to discover novel nanomedicines using Accurins for the treatment of diseases in therapeutic areas outside of oncology.

Jun 19th, 2014

Read more

OCSiAl Acquires Zyvex Technologies

OCSiAl, a leading technology manufacturer for the mass industrial production of graphene tubes, announced today at a press conference at the TechConnect World Innovation Conference that it has acquired Zyvex Technologies.

Jun 16th, 2014

Read more